title: Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia.
authors.affiliation: Howard University College of Medicine, Washington, DC 20009.
authors.forename: G W
authors.initials: GW
authors.lastname: Jones
authors.forename: R A
authors.initials: RA
authors.lastname: Smith
authors.forename: J D
authors.initials: JD
authors.lastname: Batjer
authors.forename: D G
authors.initials: DG
authors.lastname: Bostwick
authors.forename: B W
authors.initials: BW
authors.lastname: Corn
authors.forename: H A
authors.initials: HA
authors.lastname: Guess
authors.forename: M A
authors.initials: MA
authors.lastname: Hudson
authors.forename: J
authors.initials: J
authors.lastname: Kabalin
authors.forename: M S
authors.initials: MS
authors.lastname: Soloway
mesh_terms: D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000628:therapy
chemical_list: D017430:Prostate-Specific Antigen